Kusatsu, Japan

Teruya Nakamura


Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 125(Granted Patents)


Location History:

  • Muko, JA (1977)
  • Muko, JP (1978)
  • Kyoto, JP (1980)
  • Shiga, JP (1988)
  • Kusatsu, JP (1984 - 1995)

Company Filing History:


Years Active: 1977-1995

Loading Chart...
26 patents (USPTO):

Title: **Teruya Nakamura: Innovator in Biotechnology**

Introduction

Teruya Nakamura, an esteemed inventor based in Kusatsu, Japan, has made significant contributions to the field of biotechnology with a total of 26 patents to his name. His innovative work primarily focuses on the development of advanced enzymes and antibiotics.

Latest Patents

Among Nakamura's latest patents is a remarkable restriction enzyme derived from Brevibacterium linens. This enzyme is cultivated from a specific strain and boasts the same specificity as AvrII, cleaving a nucleotide sequence precisely at designated sites. Additionally, he holds a patent for an antibiotic, R106, which is represented by a specific general formula. This antibiotic is notable for its potential applications in treating bacterial infections, showcasing Nakamura's commitment to addressing healthcare challenges.

Career Highlights

Nakamura's impressive career includes significant positions at renowned companies such as Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai and Takara Shuzo Co., Inc. His tenure at these institutions allowed him to cultivate his innovative ideas and push the boundaries of scientific research.

Collaborations

Throughout his career, Nakamura has collaborated with esteemed colleagues, including Tomio Takeuchi and Hamao Umezawa. These partnerships have fostered an environment of shared knowledge and creativity, propelling forward the advancements in their respective fields.

Conclusion

Teruya Nakamura stands out as a pioneering inventor within the biotechnology sector. His groundbreaking patents and collaborative efforts with fellow researchers have significantly enhanced our understanding and application of enzymes and antibiotics. As he continues to innovate, the impact of his work is sure to resonate throughout the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…